The biotech companies you should keep an eye out for in 2024
Welcome to the 55 new subscribers who joined our LinkedIn newsletter last week ❤️ If not done yet, subscribe to join the 5,033 fans of the Pick of the Week!
As 2023 comes to a close, the biotechnology industry is brimming with potential, with many companies currently spearheading scientific innovation.
And in 2024, it's likely that we will continue to see the same.
In fact, a diverse range of companies are poised to break new ground when it comes to tackling global challenges.
This week we take a look at nine exciting biotech companies we think you should look out for in 2024.
To find out more, read the full article: "Nine biotech companies to watch in 2024"
Recommended by LinkedIn
🔥 More noteworthy articles from this week:
Although there is currently no cure for glioblastoma, CAR-T cell therapy has shown success in preclinical and early clinical studies and could be the best hope for successfully treating - and perhaps even curing - this aggressive form of brain cancer.
Precision medicine - which tailors treatments based on people’s genetic makeup, lifestyle, and environment - can tackle a range of diseases, and there are now many biopharma companies focused on this type of approach, hoping to get their clinical candidates to market.
After a difficult few years, there is now hope that 2024 will bring the funds for vital clinical research and cutting-edge technology that could redefine care for diseases and conditions that have limited or non-existent treatment options.
💡Enjoying these articles? Never miss a single publication of Labiotech by becoming a part of our community! Click here to join our mailing list.